Evolent Health, Inc. financial data

Symbol
EVH on NYSE
Location
1812 North Moore St, Suite 1705, Arlington, VA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 101 % -2.21%
Debt-to-equity 159 % +24.4%
Return On Assets -5.07 % -80.9%
Operating Margin -3.63 % -1448%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 112M shares -4.26%
Entity Public Float 2.2B USD -35.3%
Common Stock, Value, Issued 1.18M USD +0.86%
Weighted Average Number of Shares Outstanding, Basic 114M shares -0.69%
Weighted Average Number of Shares Outstanding, Diluted 114M shares -0.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.96B USD +45.3%
Revenue from Contract with Customer, Excluding Assessed Tax 2.05B USD -16.6%
Cost of Revenue 1.68B USD -19.1%
Costs and Expenses 2.07B USD -17.3%
Operating Income (Loss) -20.5M USD +52.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -128M USD -46.5%
Income Tax Expense (Benefit) 430K USD
Net Income (Loss) Attributable to Parent -128M USD -77.5%
Earnings Per Share, Basic -1 USD/shares -73.6%
Earnings Per Share, Diluted -1 USD/shares -73.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117M USD +20.8%
Accounts Receivable, after Allowance for Credit Loss, Current 387M USD -5.23%
Assets, Current 570M USD +4.8%
Property, Plant and Equipment, Net 80.1M USD +8.31%
Operating Lease, Right-of-Use Asset 4.84M USD -47.7%
Intangible Assets, Net (Excluding Goodwill) 624M USD -10.5%
Goodwill 1.08B USD -5.45%
Assets 2.45B USD -1.93%
Accounts Payable, Current 72.2M USD +44.1%
Employee-related Liabilities, Current 55.4M USD +75.2%
Accrued Liabilities, Current 60.9M USD -49.4%
Contract with Customer, Liability, Current 1.87M USD -28.6%
Liabilities, Current 430M USD -17.9%
Contract with Customer, Liability, Noncurrent 220K USD -24.9%
Deferred Income Tax Liabilities, Net 10.2M USD -14.6%
Operating Lease, Liability, Noncurrent 4.43M USD -84.9%
Other Liabilities, Noncurrent 3.78M USD +16.5%
Liabilities 1.61B USD +26.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.38M USD -73.8%
Retained Earnings (Accumulated Deficit) -886M USD -16.9%
Stockholders' Equity Attributable to Parent 842M USD -18.9%
Liabilities and Equity 2.45B USD -1.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.57M USD -7.01%
Net Cash Provided by (Used in) Financing Activities 108M USD +625%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -34.5%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 118M shares +0.87%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 99.3M USD +891%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 143M USD +11.9%
Deferred Tax Assets, Valuation Allowance 47.8M USD +49.5%
Deferred Tax Assets, Gross 194M USD -2.56%
Operating Lease, Liability 22.4M USD -37%
Depreciation 27.4M USD -10.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -182M USD -74.3%
Lessee, Operating Lease, Liability, to be Paid 23.5M USD -45.7%
Property, Plant and Equipment, Gross 280M USD +13.3%
Operating Lease, Liability, Current 17.9M USD +188%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.2M USD -70.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.8M USD +89.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +13.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.09M USD -85.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 977K USD -86%
Deferred Tax Assets, Operating Loss Carryforwards 125M USD +1.71%
Unrecognized Tax Benefits 2.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 548K USD -90.6%
Operating Lease, Payments 3.53M USD -7.89%
Additional Paid in Capital 1.79B USD -1.48%
Amortization of Intangible Assets 72.8M USD -17.6%
Depreciation, Depletion and Amortization 24.1M USD -18.5%
Deferred Tax Assets, Net of Valuation Allowance 146M USD -12.6%
Share-based Payment Arrangement, Expense 31.2M USD -44.7%
Interest Expense 47.3M USD +80.4%